Sold as Quinidex. Every FDA application for this active ingredient: 1 branded and 47 generic.
As of Nov 16, 2026, FDA lists 48 applications for Quinidine Sulfate (sold as Quinidex), first approved Feb 21, 1962, with 1 new use approved and 0 published complete response letters.
| Product | Part | Spending, 2025 | Change | Beneficiaries |
|---|---|---|---|---|
| Quinidine Sulfate | Part D | $2.1M | +12% | 627 |
| Feb 21, 1962 | QuinidexNDA 12796 · New dosage form | Wyeth Pharms Inc | 38 | Discontinued |
| Jul 15, 1975 | Quinidine SulfateANDA 83640 | Cycle | 11 | Discontinued |
| Jan 16, 1976 | Quinidine SulfateANDA 83879 | Warner Chilcott | 0 | Discontinued |
| Jul 8, 1976 | Quinidine SulfateANDA 85038 | Lilly | 0 | Discontinued |
| Jul 8, 1976 | Quinidine SulfateANDA 85103 | Lilly | 1 | Discontinued |
| Aug 31, 1976 | Quinidine SulfateANDA 84549 | Ivax Sub Teva Pharms | 1 | Discontinued |
| Sep 2, 1976 | Quinidine SulfateANDA 83862 | Hikma | 8 | Discontinued |
| Sep 30, 1976 | Quinidine SulfateANDA 84177 | Barr | 1 | Discontinued |
| Oct 6, 1976 | Quinidine SulfateANDA 84003 | Purepac Pharm | 3 | Discontinued |
| Nov 24, 1976 | Quinidine SulfateANDA 83288 | Watson Labs | 22 | Discontinued |
| Nov 24, 1976 | Quinidine SulfateANDA 84631 | Sandoz | 11 | Discontinued |
| Dec 8, 1976 | Quinidine SulfateANDA 83347 | Impax Labs | 5 | Discontinued |
| Dec 13, 1976 | Quinidine SulfateANDA 85140 | Watson Labs | 18 | Discontinued |
| Jan 14, 1977 | Quinidine SulfateANDA 83743 | Chartwell Molecular | 3 | Discontinued |
| Feb 1, 1977 | Quinidine SulfateANDA 85068 | Scherer Labs | 0 | Discontinued |
| Feb 14, 1977 | Quinidine SulfateANDA 83808 | Contract Pharmacal | 8 | Discontinued |
| Apr 29, 1977 | Quinidine SulfateANDA 83393 | Valeant Pharm Intl | 0 | Discontinued |
| Aug 2, 1977 | Quinidine SulfateANDA 85632 | Cycle | 9 | Discontinued |
| Aug 18, 1977 | Quinidine SulfateANDA 84914 | Sandoz | 17 | Discontinued |
| Jul 13, 1978 | Quinidine SulfateANDA 85444 | Whiteworth Town Plsn | 5 | Discontinued |
| Aug 29, 1979 | Quinidine SulfateANDA 87011 | Dava Pharms Inc | 13 | Discontinued |
| Jun 9, 1981 | Quinidine SulfateANDA 85584 | Watson Labs | 3 | Discontinued |
| Jun 9, 1981 | Quinidine SulfateANDA 85583 | Watson Labs | 15 | Discontinued |
| Apr 14, 1982 | Quinidine SulfateANDA 87837 | Usl Pharma | 0 | Discontinued |
| Jul 13, 1982 | Quinidine SulfateANDA 87909 | Vangard | 1 | Discontinued |
| Sep 26, 1983 | Quinidine SulfateANDA 88072 | Epic Pharma LLC | 10 | Marketed |
| Sep 29, 1988 | Quinidine SulfateANDA 89839 | Chartwell Rx | 6 | Discontinued |
| Apr 14, 1989 | Quinidine SulfateANDA 81029 | Sun Pharm Industries | 8 | Discontinued |
| Apr 14, 1989 | Quinidine SulfateANDA 81030 | Sun Pharm Industries | 12 | Discontinued |
| Apr 14, 1989 | Quinidine SulfateANDA 81031 | Sun Pharm Industries | 10 | Discontinued |
| Jun 30, 1994 | Quinidine SulfateANDA 40045 | Cosette Pharms Nc | 11 | Discontinued |
| — | QuinoraANDA 85222 | Schering | 0 | Discontinued |
| — | Quinidine SulfateANDA 83439 | Everylife | 0 | Discontinued |
| — | Quinidine SulfateANDA 84627 | Pharmavite | 0 | Discontinued |
| — | QuinoraANDA 83576 | Key Pharms | 0 | Discontinued |
| — | Quinidine SulfateANDA 83583 | Halsey | 0 | Discontinued |
| — | Quinidine SulfateANDA 83622 | Elkins Sinn | 0 | Discontinued |
| — | Quinidine SulfateANDA 83963 | Vintage Pharms | 0 | Discontinued |
| — | Cin-QuinANDA 84932 | Solvay | 0 | Discontinued |
| — | Quinidine SulfateANDA 85175 | King Pharms | 0 | Discontinued |
| — | Quinidine SulfateANDA 85276 | Kv Pharm | 0 | Discontinued |
| — | Cin-QuinANDA 85296 | Solvay | 0 | Discontinued |
| — | Cin-QuinANDA 85297 | Solvay | 0 | Discontinued |
| — | Cin-QuinANDA 85298 | Solvay | 0 | Discontinued |
| — | Cin-QuinANDA 85299 | Solvay | 0 | Discontinued |
| — | Quinidine SulfateANDA 85322 | Perrigo | 0 | Discontinued |
| — | Quinidine SulfateANDA 86176 | Lederle | 0 | Discontinued |
| — | Quinidine SulfateANDA 88973 | Superpharm | 0 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA